14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 25 Apr 2024

Trading levels for CSBR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.10 0.526 %
R2 5.08 0.225 %
R1 5.07 0.0384 %
Current price: 5.07
Support S1 5.04 -0.564 %
S2 5.03 -0.751 %
S3 5.02 -1.05 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.81 14.60 %
R2 5.70 12.43 %
R1 5.50 8.48 %
Current price 5.07
Support S1 5.02 -0.99%
S2 5.00 -1.38%
S3 4.98 -1.78%

CSBR Predictions History

2 years ago
JS predicted that CSBR for 2022-03-28 is going $8.39 (-1.06%)

4 years ago
joe1234 predicted that CSBR for 2019-05-28 is going $10.35 (9.29%)

4 years ago
joe1234 predicted that CSBR for 2019-05-07 is going $9.51 (2.92%)

4 years ago
joe1234 predicted that CSBR for 2019-05-06 is going $8.80 (-6.08%)

4 years ago
NameNotImportant predicted that CSBR for 2019-05-02 is going $9.07 (1.68%)

5 years ago
JS predicted that CSBR for 2018-09-19 is going $11.97 (-14.38%)

7 years ago
JS predicted that CSBR for 2017-01-20 is going $3.63 (-1.63%)

7 years ago
Mike.Smith.2349 predicted that CSBR for 2017-01-20 is going $3.78 (2.16%)

Rank:

7 years ago
Wilks.Holmes.2211 predicted that CSBR for 2017-01-20 is going $3.92 (5.95%)

Rank:

7 years ago
amy..2282 predicted that CSBR for 2017-01-20 is going $3.87 (4.59%)

Rank:
Click to get the best stock tips daily for free!

About Champions Oncology

Champions Oncology Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune... CSBR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT